Related references
Note: Only part of the references are listed.Lower irisin level in patients with type 2 diabetes mellitus: A case-control study and meta-analysis
Chun Zhang et al.
JOURNAL OF DIABETES (2016)
Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer
Christoph Scholz et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Irisin in Response to Exercise in Humans With and Without Metabolic Syndrome
Joo Young Huh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Serum Irisin Levels Are Regulated by Acute Strenuous Exercise
Dennis Loeffler et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Elevated Circulating Levels of Irisin and the Effect of Metformin Treatment in Women With Polycystic Ovary Syndrome
Minyan Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study
Shuyu Yang et al.
BMC NEPHROLOGY (2015)
Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro
Nicholas P. Gannon et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events
K. N. Aronis et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies
D. S. M. Chan et al.
ANNALS OF ONCOLOGY (2014)
Serum levels of the myokine irisin in relation to metabolic and renal function
Thomas Ebert et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans
Frode Norheim et al.
FEBS JOURNAL (2014)
Circulating Irisin and Glucose-Dependent Insulinotropic Peptide Are Associated With the Development of Polycystic Ovary Syndrome
Chia Lin Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Circulating Irisin in Healthy, Young Individuals: Day-Night Rhythm, Effects of Food Intake and Exercise, and Associations With Gender, Physical Activity, Diet, and Body Composition
Athanasios D. Anastasilakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies
Timea Kurdiova et al.
JOURNAL OF PHYSIOLOGY-LONDON (2014)
Irisin in patients with nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Regulation of cell proliferation and malignant potential by irisin in endometrial, colon, thyroid and esophageal cancer cell lines
Hyun-Seuk Moon et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Irisin: A potentially candidate marker for myocardial infarction
Tuncay Kuloglu et al.
PEPTIDES (2014)
A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues
Suleyman Aydin et al.
PEPTIDES (2014)
Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index
Maria Pardo et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Serum irisin levels in new-onset type 2 diabetes
Yeon-Kyung Choi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome
Kyung Hee Park et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance
Jose Mara Moreno-Navarrete et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Lower circulating irisin is associated with type 2 diabetes mellitus
Jian-Jun Liu et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?
Satu Pekkala et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
FNDC5/Irisin Is Not Only a Myokine but Also an Adipokine
Arturo Roca-Rivada et al.
PLOS ONE (2013)
Decrease in Irisin in Patients with Chronic Kidney Disease
Ming-Shien Wen et al.
PLOS ONE (2013)
Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - Correlation with body mass index
Andreas Stengel et al.
PEPTIDES (2013)
Irisin, Two Years Later
Marta G. Novelle et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2013)
The Impact of Obesity on Breast Cancer: A Retrospective Review
Danielle J. Haakinson et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human
Jun Wu et al.
CELL (2012)
Expression of the Irisin Precursor FNDC5 in Skeletal Muscle Correlates With Aerobic Exercise Performance in Patients With Heart Failure
Stewart H. Lecker et al.
CIRCULATION-HEART FAILURE (2012)
Is irisin a human exercise gene?
James A. Timmons et al.
NATURE (2012)
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Pontus Bostroem et al.
NATURE (2012)
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise
Joo Young Huh et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Molecular mechanisms of leptin and adiponectin in breast cancer
Thierry Jarde et al.
EUROPEAN JOURNAL OF CANCER (2011)
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
Marianne Ewertz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
CA 15-3: Uses and limitation as a biomarker for breast cancer
Michael J. Duffy et al.
CLINICA CHIMICA ACTA (2010)
Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications
Antonio Maccio et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
Daphne P. Guh et al.
BMC PUBLIC HEALTH (2009)
The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study
Anne E. Cust et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Circulating levels of leptin, adiposity and breast cancer risk
M-H Wu et al.
BRITISH JOURNAL OF CANCER (2009)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Anthropometric measures, plasma adiponectin, and breast cancer risk
Yu-Feng Tian et al.
ENDOCRINE-RELATED CANCER (2007)
Unexpected evidence for active brown adipose tissue in adult humans
Jan Nedergaard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Plasma adiponectin concentrations and risk of incident breast cancer
Shelley S. Tworoger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Relationship of serum adiponectin and resistin levels with breast cancer risk
Jee-Hyun Kang et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Linda Vona-Davis et al.
ENDOCRINE-RELATED CANCER (2007)
The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer
Chien-Liang Liu et al.
ONCOLOGY (2007)
Serum adiponectin and leptin levels in Taiwanese breast cancer patients
Da-Chung Chen et al.
CANCER LETTERS (2006)
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli
C Garofalo et al.
CLINICAL CANCER RESEARCH (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Association between adiponectin, insulin resistance, and endometrial cancer
Pamela T. Soliman et al.
CANCER (2006)
Molecular links between obesity and breast cancer
A. M. Lorincz et al.
ENDOCRINE-RELATED CANCER (2006)
Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study
EK Wei et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Adiponectin: Identification, physiology and clinical relevance in metabolic and vascular disease
Y Matsuzawa
ATHEROSCLEROSIS SUPPLEMENTS (2005)
Serum levels of leptin, insulin, and lipids in relation to breast cancer in China
CZ Han et al.
ENDOCRINE (2005)
Adiponectin and breast cancer risk
C Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Circulating adiponectin and endometrial cancer risk
L Dal Maso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Body size and breast cancer risk:: Findings from the european prospective investigation into cancer and nutrition (EPIC)
PH Lahmann et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer
M Ishikawa et al.
CLINICAL CANCER RESEARCH (2004)
Brown adipose tissue: Function and physiological significance
B Cannon et al.
PHYSIOLOGICAL REVIEWS (2004)
Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer
ER Sauter et al.
HORMONE AND METABOLIC RESEARCH (2004)
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
M Cnop et al.
DIABETOLOGIA (2003)
Plasma adiponectin concentrations in relation to endometrial cancer: A case-control study in Greece
E Petridou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Leptin and insulin growth factor I in relation to breast cancer (Greece)
E Petridou et al.
CANCER CAUSES & CONTROL (2000)
Tumour marker measurements in the diagnosis and monitoring of breast cancer
KL Cheung et al.
CANCER TREATMENT REVIEWS (2000)
Share Paper
